For 2020, 29 EU/EEA Member States reported 14 428 cases of hepatitis B virus (HBV) infection. Excluding the five countries that only reported acute cases, the number of cases (14 137) corresponds to a crude rate of 4.2 cases per 100 000 population.
This report presents findings related to the hepatitis B and C continuum of care, policy on testing and treatment, and the impact of the COVID-19 pandemic on hepatitis services in the EU/EEA from the second data collection conducted in 2021.
ECDC provides support to EU/EEA countries in monitoring their progress towards the hepatitis elimination targets and has just published a report based on the second data collection.
Online directory with guidance on prevention and control of Clostridioides difficile infection (CDI), published by ECDC, EU/EEA Member States, international and national agencies and professional societies
This document assesses the risk of further spread of S. sonnei amongst MSM and in the broader population in EU/EEA countries, resulting from the current increase in extensively-drug resistant S. sonnei infections.